A Soluble Form of Fibroblast Growth Factor Receptor 2 (FGFR2) with S252W Mutation Acts as an Efficient Inhibitor for the Enhanced Osteoblastic Differentiation Caused by FGFR2 Activation in Apert Syndrome

収録刊行物

被引用文献 (8)*注記

もっと見る

関連プロジェクト

もっと見る

問題の指摘

ページトップへ